US Stock MarketDetailed Quotes

CING Cingulate

Watchlist
  • 0.8787
  • -0.0073-0.82%
Close Apr 23 16:00 ET
4.40MMarket Cap-33P/E (TTM)

About Cingulate Company

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.

Company Profile

SymbolCING
Company NameCingulate
Listing DateDec 8, 2021
Issue Price6.00
Founded2013
CEODr. Shane J. Schaffer, Pharm.D.
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1901 West 47th Place
CityKansas City
ProvinceKansas
CountryUnited States of America
Zip Code66205
Phone1-913-942-2300
Websitehttp://www.cingulate.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Shane J. Schaffer, Pharm.D.
  • Chief Executive Officer and Chairman of the Board
  • 1.40M
  • Jennifer L. Callahan
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Matthew N. Bra M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Dr. Raul R. Silva, M.D.
  • Executive Vice President and Chief Science Officer
  • --
  • Laurie A. Myers, PhD
  • Executive Vice President and Chief Operating Officer
  • 748.30K
  • Jeffrey S. Ervin
  • Independent Director
  • --
  • Bryan Lawrence
  • Independent Director
  • --
  • John A. Roberts
  • Independent Director
  • --
  • Peter J. Werth
  • Independent Director
  • 47.54K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg